Thomas P.

contributor article Canonical chemokine receptors as scavenging “decoys” Shivani Sachdev, Brendan Creemer, Thomas Gardella, and Ross Cheloha for their work on Highly biased agonism for GPCR ligands via nanobody tethering

November 2021 "So proud and grateful to receive honorary doctorate yesterday from Karolinska Institute and celebrate with my family in Stockholm." Read more at the source #DrGPCR #GPCR #IndustryNews

This Week’s Highlights: Celebrating Excellence: Hyoungjun Ham , Yamina Berchiche , Thomas Sakmar , Vladimir mutations in a G protein identify signaling cross-talk in T cells Victoria Saca , Colin Burdette , and Thomas

for their work on GPCR gene variants and human genetic disease Ilana Kotliar , Thomas Sakmar , et al.

Bryan Roth, Peter Gmeiner, and Thomas P. Sakmar this week. For Dr.

Thomas P.

-A., Thomas, T., Nguyen, T. D., Muñoz, L. L., Gregory, K. J., White, P. J., Sexton, P.

Thomas P. Sakmar, Debbie L. Hay, Lukas Grätz, and more.

Thomas Südhof, but did not start working on them right away.

T., Gardella, T. J., & Vilardaga, J. P. (2009).

towards previously established chemical space, limiting their ability to identify truly novel chemotypes”(Thomas

Awards Baxter Prize to Innovator in Endocrine Drug Discovery Upstream Bio Announces the Appointment of Marcella

Aylin Hanyaloglu, Caroline Gorvin, and Alejandra Tomas.

Alejandra Tomas, et al. for their research on Engineered mini-G proteins block the internalization of

ß-arrestin functional specificity at C-X-C chemokine receptor 5 (CXCR5) Panjamaporn Sangwung , Alejandra Tomas

Alejandra Tomas, et al. for their study on Lipid regulation of the glucagon receptor family Drs.